Stock Analysis

Naba Al Saha Medical Services Company's (TADAWUL:9546) Senior Key Executive Nayef Mohammed Hassan Al-Jishi is the most upbeat insider, and their holdings increased by 15% last week

Published
SASE:9546

Key Insights

  • Naba Al Saha Medical Services' significant insider ownership suggests inherent interests in company's expansion
  • A total of 2 investors have a majority stake in the company with 50% ownership
  • Past performance of a company along with ownership data serve to give a strong idea about prospects for a business

A look at the shareholders of Naba Al Saha Medical Services Company (TADAWUL:9546) can tell us which group is most powerful. The group holding the most number of shares in the company, around 64% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential (or downside risk).

As a result, insiders were the biggest beneficiaries of last week’s 15% gain.

Let's take a closer look to see what the different types of shareholders can tell us about Naba Al Saha Medical Services.

Check out our latest analysis for Naba Al Saha Medical Services

SASE:9546 Ownership Breakdown June 10th 2024

What Does The Lack Of Institutional Ownership Tell Us About Naba Al Saha Medical Services?

Small companies that are not very actively traded often lack institutional investors, but it's less common to see large companies without them.

There are multiple explanations for why institutions don't own a stock. The most common is that the company is too small relative to funds under management, so the institution does not bother to look closely at the company. Alternatively, there might be something about the company that has kept institutional investors away. Naba Al Saha Medical Services' earnings and revenue track record (below) may not be compelling to institutional investors -- or they simply might not have looked at the business closely.

SASE:9546 Earnings and Revenue Growth June 10th 2024

Hedge funds don't have many shares in Naba Al Saha Medical Services. From our data, we infer that the largest shareholder is Nayef Mohammed Hassan Al-Jishi (who also holds the title of Senior Key Executive) with 30% of shares outstanding. Its usually considered a good sign when insiders own a significant number of shares in the company, and in this case, we're glad to see a company insider play the role of a key stakeholder. With 20% and 14% of the shares outstanding respectively, Nathir Mohammed Hassan Al-Jishi and Lesley Al-Jishi are the second and third largest shareholders. Interestingly, the second-largest shareholder, Nathir Mohammed Hassan Al-Jishi is also Chief Executive Officer, again, pointing towards strong insider ownership amongst the company's top shareholders.

A more detailed study of the shareholder registry showed us that 2 of the top shareholders have a considerable amount of ownership in the company, via their 50% stake.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.

Insider Ownership Of Naba Al Saha Medical Services

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our most recent data indicates that insiders own the majority of Naba Al Saha Medical Services Company. This means they can collectively make decisions for the company. That means they own ر.س612m worth of shares in the ر.س954m company. That's quite meaningful. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

General Public Ownership

With a 24% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Naba Al Saha Medical Services. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Company Ownership

It seems that Private Companies own 12%, of the Naba Al Saha Medical Services stock. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Naba Al Saha Medical Services you should know about.

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Valuation is complex, but we're here to simplify it.

Discover if Naba Al Saha Medical Services might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.